Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mycronic AB ( (SE:MYCR) ) has provided an announcement.
Mycronic AB has secured a significant order for three mask writers from an existing customer in Asia, valued between USD 48-52 million. The order includes one Prexision 8 Evo and two Prexision Lite 8 Evo mask writers, with deliveries scheduled from the second quarter of 2026 to the first quarter of 2027. This order highlights Mycronic’s strong position in the market for display photomasks and its ability to offer tailored solutions that meet both current and future customer needs.
The most recent analyst rating on (SE:MYCR) stock is a Buy with a SEK237.00 price target. To see the full list of analyst forecasts on Mycronic AB stock, see the SE:MYCR Stock Forecast page.
More about Mycronic AB
Mycronic is a Swedish high-tech company specializing in the development, manufacture, and marketing of high-precision production equipment for the electronics industry. The company is headquartered in Täby, Sweden, and has a global presence with subsidiaries in various countries including China, France, and the United States. Mycronic is publicly traded on Nasdaq Stockholm.
YTD Price Performance: 11.50%
Average Trading Volume: 157,363
Technical Sentiment Signal: Strong Buy
Current Market Cap: SEK42.76B
For detailed information about MYCR stock, go to TipRanks’ Stock Analysis page.